Dual antiplatelet therapy after percutaneous coronary intervention according to bleeding risk (HOST-BR): an open-label, multicentre, randomised clinical trial. - Kang, Jeehoon; Park, Kyung Woo; Han, Jung-Kyu; Hwang, Doyeon; Yang, Han-Mo; Park, Sungjoon; Ahn, Hyo-Suk; Hwang, Kyung-Kuk; Kim, Byung Gyu; Jeong, Jin-Ok; Ahn, Jong-Hwa; Rhew, Jay Young; et al. (Lancet, 2025)